Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt EMA Management Board: highlights of October 2014 meeting 6 oktober 2014Press releaseCorporate Publication of clinical reports 2 oktober 2014Press releaseCorporate Facilitating applications for paediatric investigation plans 30 september 2014NewsCorporate Small and medium-sized enterprises: driving innovation in medicines 29 september 2014NewsCorporateSME Ketoconazole HRA recommended for approval in Cushing's syndrome 26 september 2014Press releaseHuman Ebola outbreak: EMA to review experimental medicines to support treatment decisions 26 september 2014Press releaseCorporate EMA confirms positive benefit-risk for antidepressant Valdoxan/Thymanax (agomelatine) 26 september 2014Press releaseHuman Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 September 2014 26 september 2014NewsHuman Harvoni recommended for the treatment of chronic hepatitis C 26 september 2014Press releaseHuman Patients to discuss benefit-risk evaluation of medicines with the Committee for Medicinal Products for Human Use 26 september 2014Press releaseHumanCorporate 1 … 188 189 190 191 192 Page 192 of 380 193 194 195 196 … 380
Small and medium-sized enterprises: driving innovation in medicines 29 september 2014NewsCorporateSME
Ebola outbreak: EMA to review experimental medicines to support treatment decisions 26 september 2014Press releaseCorporate
EMA confirms positive benefit-risk for antidepressant Valdoxan/Thymanax (agomelatine) 26 september 2014Press releaseHuman
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 September 2014 26 september 2014NewsHuman
Patients to discuss benefit-risk evaluation of medicines with the Committee for Medicinal Products for Human Use 26 september 2014Press releaseHumanCorporate